跳至主要内容
临床试验/IRCT20091023002624N21
IRCT20091023002624N21招募中2 期

Evaluation of the effects of sildenaphil on oligohydramnios in pregnant women.

Iran University of Medical Sciences0 个研究点目标入组 190 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
190

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • Informed consent
  • Singleton pregnancy
  • Gestational age 30-37 weeks
  • Amniotic fluid index (AFI) less than 5 cm which was discoveredduring third-trimester ultrasonography

排除标准

  • Abnormal fetal Doppler
  • Fetal anomalies
  • Fetal growth restriction
  • Fetal distress like nonreactive non stress test(NST)
  • Maternal chronic hypertension
  • Pre-gestational diabetes,
  • Active labor
  • Rupture of membranes
  • Treatment with prostaglandin synthase inhibitors
  • Maternal diseases contraindicating bolus fluid therapy (kidney, lung, or heart disease)

研究者

相似试验